Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223287 · ClinicalTrials.gov registry record
Physiologic Definition of Bronchopulmonary Dysplasia
A clinical trial of Infant, Newborn and Infant, Premature, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- 410
- Enrollment target
- 20
- Study locations
NCT01223287 is a study of Infant, Newborn and Infant, Premature that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 410 participants, below the 228,249-participant average among 14 other Infant, Newborn trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT01223287, a study of Infant, Newborn and Infant, Premature, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- 410 participants
- Enrollment target
- 20
- Study locations
Study Summary
This observational study was conducted to design and test a physiologic definition for bronchopulmonary dysplasia at 36 weeks of life. Infants were studied in a supine position with the pulse oximeter in position with good signal prior to collecting baseline data. Feedings and medications were given 30 minutes before the evaluation. Baseline data was collected on infant's current oxygen. Then, the infants were weaned to room air for 30 minutes. If saturations remain ≥90%, the infant was considered to have passed the oxygen reduction challenge (to NOT have BPD). The infant should then be placed back in his/her baseline oxygen. If the infant has saturations \<90% for 5 continuous minutes or \<80% for 15 seconds, the infant should be immediately placed back in his/her baseline oxygen, and the infant was considered to have NOT passed the challenge (to have BPD).
Conditions Studied
Study Locations (20)
North Carolina
- Wake Forest University - Charlotte
- RTI International - Durham
- Duke University - Durham
California
- Stanford University - Palo Alto
- University of California at San Diego - San Diego
Ohio
- Cincinnati Children's Medical Center - Cincinnati
- Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
- University of Texas Health Science Center at Houston - Houston
Alabama
- University of Alabama - Birmingham
Connecticut
- Yale University - New Haven
Florida
- University of Miami - Miami
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01223287
The ClinicalTrials.gov registry entry for NCT01223287 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228,249-participant average among 14 other Infant, Newborn trials with a reported enrollment target (100% lower). The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Infant, Newborn appearing as the primary indexed condition, and to 0 interventions.
NCT01223287 reports 20 study locations spanning 15 distinct geographic areas - top geographies include North Carolina, California, Ohio.
Frequently Asked Questions
What is clinical trial NCT01223287 about?
NCT01223287 is a clinical study titled "Physiologic Definition of Bronchopulmonary Dysplasia". This observational study was conducted to design and test a physiologic definition for bronchopulmonary dysplasia at 36 weeks of life. Infants were studied in a supine position with the pulse oximeter in position with good signal prior to collecting baseline data. Feedings and medications were given...
What is the current status of trial NCT01223287?
This trial is currently completed. The enrollment target is 410 participants. The study started on 2005-05. Estimated completion is 2008-09.
What conditions does trial NCT01223287 study?
This clinical trial studies the following conditions: Infant, Newborn, Infant, Premature, Infant, Small for Gestational Age, Infant, Low Birth Weight, Bronchopulmonary Dysplasia (BPD).
Who is sponsoring clinical trial NCT01223287?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01223287 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant, Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Generic Database of Very Low Birth Weight Infants
RECRUITING
-
Delivery Room Intervention and Evaluation Network
RECRUITING
-
Follow-up Visit of High Risk Infants
RECRUITING
-
Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children
RECRUITING · NA
-
Supraglottic Airway for Resuscitation Trial
RECRUITING · NA
-
Cerebral Function Monitoring in Premature Infants
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.